Table 2.

Clinical data prior to and three months after treatment with a fixed combination of travoprost 0.004%/timolol 0.5%, bimatoprost 0.03%/timolol 0.5% or latanoprost 0.005%/timolol 0.5% in naïve patients; n = 33.

	Travatan/Timolol			Bimatoprost/Timolol			Latanoprost/Timolol
	pre-treatment (mean±SD)	post-treatment (mean±SD)	p-value	pre-treatment (mean±SD)	post-treatment (mean±SD)	p-value	pre-treatment (mean±SD)	post-treatment (mean±SD)	p-value
Schirmer	8.95±0.21	7.18±0.73	0.00	12.45±3.85	9.95±3.68	0.03	13.77±4.72	9.09±3.65	0.00
TBUT	11.95±1.49	9.54±0.85	0.00	11.90±3.22	11.18±3.21	0.45	13.86±3.18	11.68±3.38	0.00
LGT	2.36±0.65	6.00	<0.001	2.00±1.48	3.27±1.45	0.00	0.86±1.12	1.41±1.71	0.22
OSDI	33.74±6.88	39.94±3.92	0.02	29.76±15.93	30.30±17.17	0.94	8.06±7.10	11.16±11.59	0.47
HLA-DR	39.50±70.56	88.77±116.28	0.02	126.86±149.20	95.79±108.01	0.26	176.79±185.95	172.95±167.09	0.92
IL-6	54.48±91.70	150.52±171.31	0.00	93.97±124.17	120.59±130.13	0.33	171.75±126.28	198.16±128.65	0.33
IOP	24.72±1.03	14.00±0.44	0.00	22.32±5.58	12.10±2.96	0.00	20.32±4.99	11.59±3.11	0.00